Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Metformin (Primary) ; Pioglitazone (Primary)
- Indications Diabetes mellitus; Insulin resistance
- Focus Therapeutic Use
- Acronyms RAMP
- 30 Nov 2017 Status changed from recruiting to completed.
- 26 Oct 2016 Status changed from not yet recruiting to recruiting.
- 14 Apr 2016 New trial record